Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B
LGND
Market Cap$2.01B
Close$
$76.09
28% downside
Current Fair Value
28% downsideOvervalued by 28% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.01 Billion |
|---|---|
| Enterprise Value | $1.77 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.22 |
| Beta | 0.76 |
| Outstanding Shares | 18,974,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -491.67 |
|---|---|
| PEG | 181.48 |
| Price to Sales | 13.2 |
| Price to Book Ratio | 2.46 |
| Enterprise Value to Revenue | 10.58 |
| Enterprise Value to EBIT | 455.06 |
| Enterprise Value to Net Income | -439 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Ligand Pharmaceuticals, Inc.
CEO: John Higgins